Clover Health VP discloses 311,169 RSUs in Form 3
Clover Health Investments, Corp. executive Joseph Frank Oldakowski, Vice President of Finance and Controller, filed an initial ownership report.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Clover Health Investments, Corp. executive Joseph Frank Oldakowski, Vice President of Finance and Controller, filed an initial ownership report. He beneficially owns 311,169 shares of Class A common stock underlying unvested time-based restricted stock units as of March 30, 2026. These restricted stock units were originally granted on June 16, 2025 and December 19, 2025, reflecting equity-based compensation rather than recent open-market trading.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
OLDAKOWSKI JOSEPH FRANK
Role
VP OF FINANCE AND CONTROLLER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Class A Common Stock | -- | -- | -- |
Holdings:
Class A Common Stock — 311,169 shares (Direct)
Footnotes (1)
- F1. The reported number of securities beneficially owned represents 311,169 shares of Class A common stock of Clover Health Investments, Corp. underlying unvested time-based restricted stock unit awards as of March 30, 2026. The restricted stock units were originally granted to the Reporting Person on June 16, 2025 and December 19, 2025.
Key Figures
Unvested RSUs: 311,169 shares
First grant date: June 16, 2025
Second grant date: December 19, 2025
3 metrics
Unvested RSUs
311,169 shares
Class A common stock underlying time-based RSUs as of March 30, 2026
First grant date
June 16, 2025
Original grant date for a portion of the RSUs
Second grant date
December 19, 2025
Original grant date for remaining RSUs
Key Terms
beneficially owned, time-based restricted stock unit awards, Class A common stock, Form 3
4 terms
beneficially owned financial
"The reported number of securities beneficially owned represents 311,169 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
time-based restricted stock unit awards financial
"underlying unvested time-based restricted stock unit awards as of March 30, 2026"
Class A common stock financial
"shares of Class A common stock of Clover Health Investments, Corp."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Form 3 regulatory
"INSIDER FILING DATA (Form 3)"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the CLOV Form 3 filing for Joseph Frank Oldakowski show?
The Form 3 shows Joseph Frank Oldakowski beneficially owns 311,169 shares of Clover Health Class A stock through unvested time-based restricted stock units. These equity awards were granted on June 16, 2025 and December 19, 2025 as part of his compensation.
Is the CLOV Form 3 for Joseph Oldakowski a buy or sell transaction?
The Form 3 does not report a buy or sell; it is an initial ownership statement. It lists 311,169 unvested restricted stock units representing Class A common shares that were previously granted as compensation, rather than newly purchased or sold in the market.
What type of equity awards are disclosed in the CLOV Form 3 filing?
The filing discloses time-based restricted stock unit awards tied to Clover Health Class A common stock. These RSUs total 311,169 shares and remain unvested as of March 30, 2026, with original grant dates on June 16, 2025 and December 19, 2025.
What is Joseph Oldakowski’s role at Clover Health Investments, Corp.?
He serves as Vice President of Finance and Controller at Clover Health Investments, Corp. The Form 3 identifies him as an officer rather than a director or ten percent owner, and the disclosed equity represents his compensation-related stock unit holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
